Establishing the boundaries of a healthy immune response
New research published in Immunity describes a standardized method to reproducibly measure a functional immune response in healthy donors. Conducted b...
Biomarkers for Alzheimer’s Continue to Offer Hope
As the population ages and the number of individuals diagnosed with Alzheimer's rises, there is an ever increasing need for earlier diagnosis. Detecti...
Fibrinogen Identified as a Prognostic Biomarker for Malignant Pleural Mesothelioma (MPM)
MPM is a treatment-resistant disease pathogenically related to chronic inflammation. Research recently published in the British Journal of Cancer conc...
Biomarkers Validated for Acute Kidney Injury (AKI)
A clinical test measuring tissue inhibitor of metalloproteinases (TIMP)-2 and insulin-like growth factor binding protein 7 (IGFBP7) in urine has been...
CSF Biomarkers Measure Tissue Damage Indicative of Disease Activity in Multiple Sclerosis (MS)
A recent study shows that three CSF markers, MBP, NFL and GFAp, can measure ongoing damage of oligodendrocytes, axons and astrocytes in patients with...
New Biomarker Offers Hope for Early Detection of Cardiac Injury
Myocardial infarctions and acute coronary syndrome affect nearly 1 million Americans every year. These events result in damage to the heart tissue and...
Tackling Cancer’s Heterogeneity
This article from GEN suggests tackling cancer's heterogeneity using a multipronged approach that includes current advancements in the detection of pr...